Familial Acromegaly and Bilateral Asynchronous Pheochromocytomas in a Female Patient With a MAX Mutation: A Case Report

por Mamedova, Elizaveta, Vasilyev, Evgeny, Petrov, Vasily, Buryakina, Svetlana, Tiulpakov, Anatoly, Belaya, Zhanna
Publicado 2021

RF25 | PMON147 Plasma MicroRNA Expression in Phenocopy of Multiple Endocrine Neoplasia Type 1 Compared to Patients with Acromegaly and Primary Hyperparathyroidism: Potential Biomar...

por Trukhina, Diana, Mamedova, Elizaveta, Nikitin, Alexey, Koshkin, Philipp, Belaya, Zhanna, Melnichenko, Galina
Publicado 2022

Atypical progeroid syndrome (p.E262K LMNA mutation): a rare cause of short stature and osteoporosis

por Yukina, Marina, Nuralieva, Nurana, Sorkina, Ekaterina, Troshina, Ekaterina, Tiulpakov, Anatoly, Belaya, Zhanna, Melnichenko, Galina
Publicado 2021

THU081 Differences In Circulating Microrna Levels In Genetically Confirmed Multiple Endocrine Neoplasia Type 1 And Multiple Endocrine Neoplasia Type 1 Phenocopies As Assessed By Ne...

por Trukhina, Diana A, Mamedova, Elizaveta O, Koshkin, Philipp A, Nikitin, Alexey G, Melnichenko, Galina A, Belaya, Zhanna E
Publicado 2023

Assessment of Vitamin D Metabolism in Patients with Cushing’s Disease in Response to 150,000 IU Cholecalciferol Treatment

por Povaliaeva, Alexandra, Bogdanov, Viktor, Pigarova, Ekaterina, Zhukov, Artem, Dzeranova, Larisa, Belaya, Zhanna, Rozhinskaya, Liudmila, Mel’nichenko, Galina, Mokrysheva, Natalia
Publicado 2021

Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement

por Pludowski, Pawel, Takacs, Istvan, Boyanov, Mihail, Belaya, Zhanna, Diaconu, Camelia C., Mokhort, Tatiana, Zherdova, Nadiia, Rasa, Ingvars, Payer, Juraj, Pilz, Stefan
Publicado 2022

Clinical course and outcome of patients with ACTH-dependent Cushing’s syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations

por Belaya, Zhanna, Golounina, Olga, Melnichenko, Galina, Tarbaeva, Natalia, Pashkova, Evgenia, Gorokhov, Maxim, Kalashnikov, Viktor, Dzeranova, Larisa, Fadeev, Valentin, Volchkov, Pavel, Dedov, Ivan
Publicado 2021

MON-313 Thyrotropin-Secreting Pituitary Tumors: Clinical Features, Diagnostic Criteria and Treatment Outcomes in 28 Patients

por Dimitrova, Diana A, Abdullin, Evgeniy T, Przhiyalkovskaya, Elena G, Yu. Grigoriev, Andrey, Azizyan, Vilen N, Lapshina, Anastasia M, Ye. Belaya, Zhanna, Melnichenko, Galina A
Publicado 2020

Circulating Plasma microRNA to Differentiate Cushing's Disease From Ectopic ACTH Syndrome

por Belaya, Zhanna, Khandaeva, Patimat, Nonn, Larisa, Nikitin, Alexey, Solodovnikov, Alexander, Sitkin, Ivan, Grigoriev, Andrey, Pikunov, Mikhail, Lapshina, Anastasia, Rozhinskaya, Liudmila, Melnichenko, Galina, Dedov, Ivan
Publicado 2020

A registry for patients with chronic hypoparathyroidism in Russian adults

por Gronskaia, Sofya, Melnichenko, Galina, Rozhinskaya, Liudmila, Grebennikova, Tatiana, Mamedova, Elizaveta, Pigarova, Ekaterina, Przhialkovskaya, Elena, Dzeranova, Larisa, Dedov, Ivan, Fadeyev, Valentin, Brandi, Maria Luisa, Belaya, Zhanna
Publicado 2020

THU038 Osilodrostat Dosing In Cushing’s Disease: A Pooled Analysis Of The LINC Program

por Newell-Price, John, Pivonello, Rosario, Lacroix, André, Biller, Beverly M K, Feelders, Richard, Gadelha, Mônica, Bertherat, Jérôme, Belaya, Zhanna, Piacentini, Andrea, Pedroncelli, Alberto M, Fleseriu, Maria
Publicado 2023

Differences in Menin Expression in Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1, Its Phenocopies and Sporadic Acromegaly

por Dimitrova, Diana A, Mamedova, Elizaveta O, Lapshina, Anastasia M, Azizyan, Vilen N, Grigoriev, Andrey Y, Vasilyev, Evgeny V, Tiulpakov, Anatoly N, Belaya, Zhanna E, Melnichenko, Galina A
Publicado 2021

Long-term efficacy and safety of osilodrostat in patients with Cushing’s disease: results from the LINC 4 study extension

por Gadelha, Mônica, Snyder, Peter J., Witek, Przemysław, Bex, Marie, Belaya, Zhanna, Turcu, Adina F., Feelders, Richard A., Heaney, Anthony P., Paul, Michaela, Pedroncelli, Alberto M., Auchus, Richard J.
Publicado 2023

OR27-3 Long-Term Results from the Phase III LINC 4 Study: Osilodrostat Maintained Normal Mean Urinary Free Cortisol in Patients with Cushing's Disease, with a Favorable Safety Prof...

por Auchus, Richard J, Belaya, Zhanna, Bex, Marie, Feelders, Richard A, Heaney, Anthony P, Paul, Michaela, Pedroncelli, Alberto M, Snyder, Peter J, Turcu, Adina F, Witek, Przemysław, Gadelha, Mônica
Publicado 2022

PMON162 Osilodrostat Provides Sustained Clinical Benefits and Improves Health-Related Quality of Life in Patients with Cushing's Disease: Results from the Phase III LINC 4 Study

por Feelders, Richard, Gadelha, Mônica, Bex, Marie, Witek, Przemyslaw, Belaya, Zhanna, Yu, Yerong, Turcu, Adina F, Heaney, Anthony P, Auchus, Richard J, Piacentini, Andrea, Pedroncelli, Alberto M, Snyder, Peter J
Publicado 2022

Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism

por Minisola, Salvatore, Arnold, Andrew, Belaya, Zhanna, Brandi, Maria Luisa, Clarke, Bart L., Hannan, Fadil M., Hofbauer, Lorenz C., Insogna, Karl L., Lacroix, André, Liberman, Uri, Palermo, Andrea, Pepe, Jessica, Rizzoli, René, Wermers, Robert, Thakker, Rajesh V.
Publicado 2022

Long-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension

por Fleseriu, Maria, Newell-Price, John, Pivonello, Rosario, Shimatsu, Akira, Auchus, Richard J, Scaroni, Carla, Belaya, Zhanna, Feelders, Richard A, Vila, Greisa, Houde, Ghislaine, Walia, Rama, Izquierdo, Miguel, Roughton, Michael, Pedroncelli, Alberto M, Biller, Beverly M K
Publicado 2022

The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational S...

por Chen, Chung-Hwan, Elsalmawy, Abdulaziz H., Ish-Shalom, Sophia, Lim, Seung-Jae, AlAli, Nadia S., Cunha-Borges, Joao L., Yang, Huilin, Casas, Noemi, Altan, Lale, Belaya, Zhanna, Marin, Fernando, Moll, Thomas, Gurbuz, Sirel, Brnabic, Alan, Pavo, Imre, Florez, Sandra
Publicado 2021

Osilodrostat Is an Effective and Well-Tolerated Treatment for Cushing’s Disease (CD): Results From a Phase III Study With an Upfront, Randomized, Double-Blind, Placebo-Controlled P...

por Gadelha, Mônica, Bex, Marie, Feelders, Richard A, Heaney, Anthony P, Auchus, Richard J, Gilis-Januszewska, Aleksandra, Witek, Przemyslaw, Belaya, Zhanna, Liao, Zhihong, Ku, Chih Hao Chen, Carvalho, Davide, Roughton, Michael, Wojna, Judi, Hofstetter, Georg, Pedroncelli, Alberto M, Snyder, Peter J
Publicado 2021

Randomized Trial of Osilodrostat for the Treatment of Cushing Disease

por Gadelha, Mônica, Bex, Marie, Feelders, Richard A, Heaney, Anthony P, Auchus, Richard J, Gilis-Januszewska, Aleksandra, Witek, Przemyslaw, Belaya, Zhanna, Yu, Yerong, Liao, Zhihong, Ku, Chih Hao Chen, Carvalho, Davide, Roughton, Michael, Wojna, Judi, Pedroncelli, Alberto M, Snyder, Peter J
Publicado 2022